David Ryzhik Appointed Interim CFO of Axcelis Technologies
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy ACLS?
Source: Newsfilter
- Executive Transition: David Ryzhik has been appointed Interim CFO of Axcelis Technologies effective March 12, 2026, succeeding James Coogan, who will leave the company on April 24 to pursue a CFO opportunity in another industry, ensuring a smooth transition.
- Leadership Acknowledgment: Axcelis CEO Russell Low stated that Ryzhik's deep knowledge of the company's strategy, financial operations, and investor relations makes him an ideal candidate for the interim CFO role, with expectations for him to continue driving the merger process with Veeco.
- Strategic Focus: Ryzhik has committed to advancing Axcelis's strategic execution and integration planning with Veeco, aiming to create long-term value for shareholders, reflecting the company's proactive stance in industry consolidation.
- Financial Robustness: Coogan's tenure established a strong finance organization and operational discipline, and Ryzhik's appointment is seen as a significant step towards achieving the company's value creation objectives, indicating a solid financial and strategic position.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACLS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACLS
Wall Street analysts forecast ACLS stock price to rise
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 86.220
Low
94.00
Averages
99.67
High
105.00
Current: 86.220
Low
94.00
Averages
99.67
High
105.00
About ACLS
Axcelis Technologies, Inc. provides high-productivity solutions for the semiconductor industry. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The Company's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. It also offers its customers aftermarket service and support.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Executive Change: Axcelis Technologies has appointed David Ryzhik as interim CFO effective March 12, 2026, with Ryzhik currently serving as Senior Vice President of Investor Relations and Corporate Strategy, indicating the company's focus on leadership stability.
- Leadership Transition: Former CFO James Coogan will leave the company on April 24, 2026, to pursue a CFO role at another public company, with Coogan remaining until then to support the leadership transition, ensuring operational continuity.
- Financial Outlook: Axcelis anticipates flat revenue for 2026, as growth in the memory market offsets declines in power and mature markets, reflecting the company's cautious stance amid market fluctuations.
- Earnings Review: Axcelis recently released its Q4 2025 earnings report, and despite a lack of confidence in a recovery, the company is striving to maintain stable financial performance.
See More
- Executive Transition: David Ryzhik has been appointed Interim CFO of Axcelis Technologies effective March 12, 2026, following James Coogan's departure to pursue a CFO role in another industry, ensuring continuity in financial leadership during this critical period.
- Transition Management: Coogan will remain until April 24 to facilitate a smooth transition, while Ryzhik's significant role in the pending merger with Veeco positions him to continue driving leadership within the finance organization.
- Strategic Execution: Ryzhik emphasized his focus on executing the company's strategy, advancing integration efforts with Veeco, and driving long-term shareholder value, highlighting the company's commitment to financial stability during the merger process.
- Extensive Experience: With over 20 years of finance and investor relations experience, Ryzhik has served as Senior Vice President of Investor Relations and Corporate Strategy at Axcelis since July 2024, and his background is expected to support the company in maintaining financial robustness during the transition.
See More
- Executive Transition: David Ryzhik has been appointed Interim CFO of Axcelis Technologies effective March 12, 2026, succeeding James Coogan, who will leave the company on April 24 to pursue a CFO opportunity in another industry, ensuring a smooth transition.
- Leadership Acknowledgment: Axcelis CEO Russell Low stated that Ryzhik's deep knowledge of the company's strategy, financial operations, and investor relations makes him an ideal candidate for the interim CFO role, with expectations for him to continue driving the merger process with Veeco.
- Strategic Focus: Ryzhik has committed to advancing Axcelis's strategic execution and integration planning with Veeco, aiming to create long-term value for shareholders, reflecting the company's proactive stance in industry consolidation.
- Financial Robustness: Coogan's tenure established a strong finance organization and operational discipline, and Ryzhik's appointment is seen as a significant step towards achieving the company's value creation objectives, indicating a solid financial and strategic position.
See More
- Investor Conference Participation: Axcelis Technologies has announced its plans to participate in upcoming investor conferences, aiming to enhance investor engagement and increase market visibility, thereby laying the groundwork for future capital raising and business expansion.
- Industry Leadership: As a leading supplier in the semiconductor industry, Axcelis has dedicated over 45 years to providing innovative, high-productivity solutions, further solidifying its market leadership in ion implantation systems.
- Commitment to Technological Innovation: The company's focus on developing enabling applications for the semiconductor manufacturing process demonstrates its ongoing commitment to technological innovation, aimed at meeting evolving market demands and driving industry advancement.
- Comprehensive Lifecycle Support: Axcelis offers design, manufacturing, and complete lifecycle support for ion implantation systems, ensuring customers receive efficient technical support and services throughout the production process, enhancing customer satisfaction and loyalty.
See More
- Investor Conference Schedule: Axcelis will participate in the Susquehanna Financial Group's 15th Annual Technology Conference on February 26, 2026, at the Lotte Palace Hotel in New York, where management will hold one-on-one and small group meetings with interested investors to enhance engagement and transparency.
- Multiple Conference Participation: The company will also attend the Morgan Stanley Technology, Media & Telecom Conference from March 2-5, 2026, in San Francisco, with management planning group discussions on March 3 to further expand investor relations.
- Virtual Meeting Options: Axcelis will offer virtual one-on-one and small group meetings at the Loop Capital Markets 7th Annual Investor Conference on March 9, 2026, demonstrating the company's commitment to flexibility and adaptability to meet diverse investor needs.
- Industry Impact: By participating in several key investor conferences, Axcelis aims to enhance its visibility and influence in the semiconductor industry while strengthening communication with investors to drive future growth and development.
See More
- Strong Economic Data: US December capital goods new orders rose 0.6% month-over-month, exceeding expectations of 0.3%, indicating a rebound in capital spending that boosts market confidence and drives stock prices higher.
- Housing Market Recovery: December housing starts increased by 6.2% month-over-month to 1.404 million, significantly surpassing the expected 1.304 million, suggesting a recovery in the housing market that could stimulate investment and consumption in related sectors.
- Manufacturing Production Growth: January manufacturing production rose by 0.6% month-over-month, stronger than the expected 0.4%, marking the largest increase in 11 months, indicating a recovery in manufacturing that supports overall economic growth expectations.
- Optimistic Stock Market Performance: Over 75% of S&P 500 companies reported earnings that beat expectations, with Q4 earnings growth projected at 8.4%, providing strong support for the stock market despite lingering doubts about future interest rate policies.
See More









